Dr. Booth joins Kellam and Associates

We are pleased to announce the addition of Dr. Kristin Booth to our practice.  She completed her fellowship in Women’s Imaging at Henry Ford Hospital in Detroit. In addition to general mammography and breast ultrasound, she has special interest in breast MRI and PET/CT.  Dr. Booth will lead the continued development and growth of our women’s imaging division.  If you would like to learn more about Dr. Booth or the procedures she provides, please contact us at 248-693-9295 or at McLaren Lapeer 810-667-5744.

Interventional Oncology

Interventional Oncology


Interventional oncology (IO) procedures provide minimally invasive, targeted treatments for cancer patients.  IO procedures form an integral part of the multi-disciplinary team (i.e. medical oncology, surgical oncology, radiation oncology, and interventional oncology) approach in the treatment of cancer and cancer-related disorders.

Image guidance is used in combination with the most current innovations available to treat cancerous tumors, while minimizing possible injury to other body organs.  Most patients having these procedures are outpatients or require a one night stay in the hospital.

  • Some of these therapies are regional, as when treating cancers involving several areas of the liver with chemoembolization or radioembolization.
  • Others are better classified as local, as when treating focal lesions in the kidney, liver, lung and bone with cryoablation (freezing), or microwave or radiofrequency ablation (heating).

In general, these techniques are reserved for patients whose cancer cannot be surgically removed or effectively treated with systemic chemotherapy. These procedures are also frequently used in combination with other therapies provided by other members of the cancer team.

Our new Interventional Radiologist is already making an impact!





Dr. Carlos Ledezma performed the first interventional renal mass cryoablation this past week at McLaren Lapeer Region. Freezing kidney tumors using a safe minimally invasive interventional radiology treatment is a highly-effective treatment option for patients with kidney tumors.


Interventional cryoablation uses imaging to pinpoint tumors and probes to penetrate the skin to deliver freezing cold directly to a diseased tumor. Most patients go home the same day they receive treatment with minimal limitation on regular activities. With traditional laparoscopic kidney surgery, a patient remains in the hospital for several days and recovery time can be from two to four weeks.


“The procedure appears to be a good option for some patients,” says Dr. Ledezma, interventional radiologist at McLaren Lapeer Region. “It makes their hospital stay and recovery time very short and surgical stress is minimal.

The standard treatment for kidney tumors is surgery. For some patients, surgery is not an option because they are frail due to age or illness or are not able to have surgery because of other factors. If this is the case, cryoablation may be an option.”


Last year, more than 1.3 million new cancers were diagnosed in the United States. According to the American Cancer Society, more than 50,000 of these individuals were diagnosed with kidney cancer. But there is hope: More than 200,000 kidney cancer survivors are living in the United States right now. Recent advances in diagnosis, surgical procedures, and treatment options will allow even more patients to live with the disease, continuing to maintain their normal schedules and lifestyles.


“It is extremely important that individuals realize all their treatment options, especially since the incidence of kidney cancer has been steadily increasing,” says Bart Buxton, CEO & President, McLaren Lapeer Region. “I am very proud to have Dr. Ledezma join our staff and bring this state-of-the-art procedure to McLaren Lapeer Region.”